Macrophage Migration Inhibitory Factor: A Novel Biomarker in Ankylosing Spondylitis That Can Drive Spinal Fusion

被引：0
|
作者：
Ranganathan, Vidya [1 ]
Sari, Ismail [2 ]
Muralitharan, Janogini [3 ]
Anton, Ammepa [4 ]
Haroon, Nigil [2 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Toronto Western Hosp, Rheumatol, Toronto, ON M5T 2S8, Canada
[3] McMaster Univ, Hamilton, ON, Canada
[4] Univ Hlth Network, Rheumatol, Toronto, ON, Canada
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2208
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets
    Kindt, Nadege
    Journe, Fabrice
    Laurent, Guy
    Saussez, Sven
    ONCOLOGY LETTERS, 2016, 12 (04) : 2247 - 2253
  • [42] Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression
    Muramaki, M
    Hara, I
    Miyake, H
    Kamidono, S
    JOURNAL OF UROLOGY, 2005, 173 (04): : 382 - 382
  • [43] Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression
    Muramaki, M
    Miyake, H
    Yamada, Y
    Hara, I
    ONCOLOGY REPORTS, 2006, 15 (01) : 253 - 257
  • [44] Serum miR-214 as a novel biomarker for ankylosing spondylitis
    Kook, Hyun Yi
    Jin, So-Hee
    Park, Pu-Reum
    Lee, Seung-Jin
    Shin, Hong-Joon
    Kim, Tae-Jong
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (07) : 1196 - 1201
  • [45] CHOROIDAL THICKNESS IS A BIOMARKER AND CAN PREDICT THE RESPONSE TO TREATMENT IN ANKYLOSING SPONDYLITIS
    Steiner, M.
    Esteban-Ortega, M. D. M.
    Thuissard-Vasallo, I.
    Garcia-Lozano, I.
    Garcia, J.
    Perez-Blazquez, E.
    Sambricio, J.
    Garcia-Aparicio, A.
    Casco-Silva, B. F.
    Sanz, J.
    Valdes-Sanz, N.
    Fernandez-Espartero, C.
    Diaz-Valle, T.
    Gurrea-Almela, M.
    Fernandez-Leroy, J.
    Gomez-Resa, M.
    Pato, E.
    Valle, D. Diaz
    Mendez-Fernandez, R.
    Marco, M. T. Navio
    Munoz-Fernandez, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1653 - 1654
  • [46] Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis
    Torres, L.
    Klingberg, E.
    Nurkkala, M.
    Carlsten, H.
    Forsblad-d'Elia, H.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (02) : 441 - 449
  • [47] Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis
    L. Torres
    E. Klingberg
    M. Nurkkala
    H. Carlsten
    H. Forsblad-d’Elia
    Osteoporosis International, 2019, 30 : 441 - 449
  • [48] GLUCOCORTICOID SUPPRESSION OF MACROPHAGE MIGRATION INHIBITORY FACTOR
    BALOW, JE
    ROSENTHAL, AS
    JOURNAL OF EXPERIMENTAL MEDICINE, 1973, 137 (04): : 1031 - 1041
  • [49] Macrophage migration inhibitory factor in cardiovascular disease
    Zernecke, Alma
    Bernhagen, Juergen
    Weber, Christian
    CIRCULATION, 2008, 117 (12) : 1594 - 1602
  • [50] Benzisothiazolones as modulators of macrophage migration inhibitory factor
    Jorgensen, William L.
    Trofimov, Alexander
    Du, Xin
    Hare, Alissa A.
    Leng, Lin
    Bucala, Richard
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (15) : 4545 - 4549
12345